52 related articles for article (PubMed ID: 18825672)
1. Pathogenic mechanisms of neurodegeneration based on the phenotypic expression of progressive forms of immune-mediated neurologic disease.
Levin MC; Lee S; Gardner LA; Shin Y; Douglas JN; Groover CJ
Degener Neurol Neuromuscul Dis; 2012; 2():175-187. PubMed ID: 30890887
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to Non-myelin Antigens as Contributors to the Pathogenesis of Multiple Sclerosis.
Levin MC; Lee S; Gardner LA; Shin Y; Douglas JN; Cooper C
J Clin Cell Immunol; 2013 Jun; 4():. PubMed ID: 24363960
[TBL] [Abstract][Full Text] [Related]
3. Examination of the role of magnetic resonance imaging in multiple sclerosis: A problem-orientated approach.
McFarland HF
Ann Indian Acad Neurol; 2009 Oct; 12(4):254-63. PubMed ID: 20182573
[TBL] [Abstract][Full Text] [Related]
4. Gray matter atrophy in multiple sclerosis: a longitudinal study.
Fisher E; Lee JC; Nakamura K; Rudick RA
Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
[TBL] [Abstract][Full Text] [Related]
5. Visualizing the cause of gray matter atrophy in multiple sclerosis.
Richert ND; Kraft E; Stüve O
Arch Neurol; 2009 Feb; 66(2):159-60. PubMed ID: 19204151
[No Abstract] [Full Text] [Related]
6. At the heart of primary progressive multiple sclerosis: three cases with diffuse MRI abnormalities only.
Zwemmer JN; Bot JC; Jelles B; Barkhof F; Polman CH
Mult Scler; 2008 Apr; 14(3):428-30. PubMed ID: 18208890
[TBL] [Abstract][Full Text] [Related]
7. Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study.
Ramasamy DP; Benedict RH; Cox JL; Fritz D; Abdelrahman N; Hussein S; Minagar A; Dwyer MG; Zivadinov R
J Neurol Sci; 2009 Jul; 282(1-2):47-54. PubMed ID: 19201003
[TBL] [Abstract][Full Text] [Related]
8. Is progressive multiple sclerosis a gray matter disease?
Geurts JJ
Ann Neurol; 2008 Sep; 64(3):230-2. PubMed ID: 18825672
[No Abstract] [Full Text] [Related]
9. Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging.
Chard D; Miller D
J Neurol Sci; 2009 Jul; 282(1-2):5-11. PubMed ID: 19201002
[TBL] [Abstract][Full Text] [Related]
10. The use of modern magnetic resonance techniques to monitor disease evolution in multiple sclerosis.
Filippi M; Rocca MA
Adv Neurol; 2006; 98():167-83. PubMed ID: 16400834
[No Abstract] [Full Text] [Related]
11. The role of MRS and fMRI in multiple sclerosis.
Tartaglia MC; Arnold DL
Adv Neurol; 2006; 98():185-202. PubMed ID: 16400835
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
